B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RACGAP1

MOLECULAR TARGET

Rac GTPase activating protein 1

UniProt: Q9H0H5NCBI Gene: 291274 compounds

RACGAP1 (Rac GTPase activating protein 1) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RACGAP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Pueraria0.691
2Kaempferols0.691
3Catechin0.691
4Equilin0.691

About RACGAP1 as a Drug Target

RACGAP1 (Rac GTPase activating protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented RACGAP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RACGAP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.